Achieve Life Sciences Quarterly Cash Flow Statement
NASDAQ: QUITHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
5.56-0.31 (-5.28%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Achieve Life Sciences free cash flow
In the quarter ended Sep 30, 2026, Achieve Life Sciences generated -$8.4 million of operating cash flow and spent $33,000 on capital expenditures. That left free cash flow of -$8.4 million.
Summary generated from market data by MetaCap's automated system. Methodology
Achieve Life Sciences cash flow statement (quarterly)
| Quarter (USD) | Q3 20262026-09-30 | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -12.11M | -74.77M | -10.17M | -14.66M | -14.44M | -12.72M | -12.83M | -12.36M | -12.51M | -8.46M | -6.49M | -5.48M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 63.00K | 58.00K | 57.00K | 57.00K | 54.00K | 55.00K | 62.00K | 58.00K | 57.00K | 57.00K | 57.00K | 57.00K |
| Stock-Based Compensation | 7.70M | 6.96M | -685.00K | 1.30M | 2.34M | 2.89M | 2.23M | 1.24M | 1.34M | 1.45M | 1.29M | -10.00K |
| Change in Working Capital | — | — | — | — | 269.00K | 68.00K | -208.00K | 1.71M | -1.14M | 146.00K | -153.00K | 538.00K |
| Operating Cash Flow | -8.36M | -10.78M | -6.93M | -17.98M | -11.33M | -9.07M | -11.09M | -9.19M | -10.37M | -4.92M | -5.29M | -4.36M |
| Capital Expenditures | -33.00K | — | — | — | — | — | — | — | — | — | — | -6.00K |
| Investing Cash Flow | -1.66M | -137.80M | 14.28M | 709.00K | -12.65M | 6.70M | 11.35M | 11.72M | 13.27M | — | — | -6.00K |
| Financing Cash Flow | 21.58M | 168.46M | 21.00K | 6.26M | 4.04M | — | — | 682.00K | -8.11M | -153.00K | 56.11M | 0 |
| Net Change in Cash | 11.56M | 19.88M | 7.36M | -11.00M | -19.94M | 38.86M | 263.00K | 3.21M | -5.21M | -51.64M | 50.82M | -4.37M |
| Free Cash Flow | -8.39M | -10.78M | -6.93M | -17.98M | -11.33M | -9.07M | -11.09M | -9.19M | -10.37M | -4.92M | -5.29M | -4.37M |
This table shows 12 quarterly periods of Achieve Life Sciences's cash flow statement, from Q3 2026 back to Q4 2023, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow QUIT's reporting calendar. What is a cash flow statement?